SCHEMBL19081870

SCHEMBL19081870

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5ccc6sc7c(ccc8oc9ccc%10ccccc%10c9c87)c6c5)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 6/20 0.38
CYP1A1 P04798 3/20 0.38
PAX8 Q06710 2/20 0.38
CYP1A2 P05177 1/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
AHR P35869 1/20 0.38
LIMK1 P53667 2/20 0.38
PGR P06401 1/20 0.36
F9 P00740 2/20 0.36
NPC1 O15118 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
CYP1B1 Q16678 2/20 0.33
RAB9A P51151 1/20 0.33
PLA2G2A P14555 1/20 0.33
PLA2G4A P47712 1/20 0.33
PIM1 P11309 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
GPR84 Q9NQS5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081979 0.94 ABCG2 (0.35) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19081903 0.93 ABCG2 (0.38) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19081875 0.92 ABCG2 (0.39) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19082049 0.90 ALOX5 (0.33) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19082024 0.90 ABCG2 (0.39) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19081855 0.89 ABCG2 (0.37) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19081894 0.87 ABCG2 (0.40) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19081823 0.87 ABCG2 (0.40) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19082195 0.87 F9 (0.38) CYP1A1CYP1A2LIMK1F9CYP1B1
SCHEMBL24341022 0.87 LIMK1 (0.37) ABCG2CYP1A1PAX8CYP1A2FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885PAX8 2336/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885PAX8 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.